David Carruthers is the founder of AbbVie. AbbVie has raised $14.7B in total funding. Latest round: Series D. Backed by Alcor Fund.
David Carruthers is the Vice President of BioPharmaceuticals and Global Head of Clinical Operations at AstraZeneca, a role he joined in 2024. He leads global operations for conducting and delivering AstraZeneca Biopharmaceuticals Clinical Trials and is also responsible for data management and insights across their clinical trials portfolio. His career in the biopharmaceutical industry includes executive positions at AbbVie and Allergan.
Full founder directory · Investor directory · Company funding database · Fundraising library